argenx SE (1AE)
FSX
Real-time Data
06:00 AM
Day's Range
879.0052 wk Range
563.40Overview - 1AE - argenx SE
Key Statistics
Valuation
Enterprise Value
42.09B
P/E (Trailing)
‪39.15‬
Price / Sales (TTM)
‪10.28‬
Price / Book
‪7.62‬
EV / EBITDA
‪30.54‬
Profitability
Gross Margin
‪90.42%‬
Profit Margin
‪32.26%‬
Operating Margin
‪31.99%‬
Return on Assets
‪11.63%‬
Return on Equity
‪23.63%‬
Ownership
Shares Outstanding
62.53M
Float
62.42M
Held by Insiders
‪0.01%‬
Held by Institutions
‪48.03%‬
Price stats
Beta
‪-0.04‬
50-Day Avg
‪780.74‬
200-Day Avg
‪717.31‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1AE - argenx SE
Peers - 1AE - argenx SE
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.38P/E (Trailing)‪29.78%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change65.56P/E (Trailing)‪10.69%‬Profit Margin
- 22UAFSXBioNTech SE25.39BMarket Cap+9.15%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
Profile Summary - 1AE - argenx SE
About
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
